- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Biochemical Pharmacology.
Displaying page 1 of 1.
EudraCT Number: 2022-001956-40 | Sponsor Protocol Number: PK_pregnancy | Start Date*: 2023-03-05 |
Sponsor Name:Medical University Vienna | ||
Full Title: Antibiotic pharmacokinetics in women with twin pregnancy | ||
Medical condition: The target population are twin pregnancy women that will deliver through c-section and that are receiving one or more of the included antibiotics. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004108-16 | Sponsor Protocol Number: HOFATA_v3.0 | Start Date*: 2022-04-21 |
Sponsor Name:Medical University Vienna | ||
Full Title: Host factors predicting target site concentration of antibiotics in critically ill patients: An explorative pharmacokinetic biomarker study | ||
Medical condition: All patients given standard of care intravenous therapy of the studied antibiotics will be screened against the inclusion criteria. Two groups are included: Group A (septic patients with organ dysf... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002553-11 | Sponsor Protocol Number: Highdoseinsulintherapy | Start Date*: 2018-02-06 | |||||||||||
Sponsor Name:Bispebjerg Hospital, University of Copenhagen | |||||||||||||
Full Title: Cardiovascular effects of high dose insulin therapy. A multi-arm, randomized, participant-and-investigator-blinded, crossover study investigating glucagon's effects on heart rate, blood pressure, a... | |||||||||||||
Medical condition: Insulin-induced increased heart rate, blood pressure and cardiac output | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005035-33 | Sponsor Protocol Number: R2477-FOP-1623 | Start Date*: 2017-08-15 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: A randomized, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and effects on heterotopic bone formation of REGN2477 in patients with Fibrodysplasia Ossificans Progres... | |||||||||||||
Medical condition: Fibrodysplasia Ossificans Progressiva (FOP) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) NL (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.